Top 10 Drug Products in India
Do you know which are the top branded drug products in India? We didn't until we found this handy chart and article. We took their IMS data a step…
Menu
Wanted: Guest Bloggers
We're actively seeking guest bloggers for LacertaBio.com! The ideal guest blogger: Is currently involved in business development and licensing Currently works for a pharma, biotech, VC, PE, or consultancy Is…
Another Day, Another Inversion
A quick search resulted in several recent examples of US-based pharma companies executing “inversions” to reduce taxes via the acquisition of companies in Ireland: Salix merges with Cosmo Technologies, the…
Reflections on BIO 2014
We're back and knee-deep in BIO2014 follow up work. Lacerta Bio was joined by 15,665 other "industry leaders" in days full of partnering discussions, pen-grabbing, eating and drinking, and…
The Industrialization of Pharma R&D
An excellent analysis of the AstraZeneca pipeline performance was recently published in Nature Review. The objective of this study was to identify and assess key factors which drive R&D performance:…
Preparing for BIO Webinar
This morning, Thompson Reuters and BIO presented a good webinar on preparing for BIO. I think it will be re-broadcast tomorrow. A lot of time was spent on characterising transactions…
More Concerns About Unaffordable Hep C Treatments
Our friends at Pharmaphorum posted an overview of the recent WHO guidance for the treatment of hepatitis C. Of note, These new oral drugs are able to cure…
Indian Pharma Industry: Is the sun setting…or rising?
Much ink has already been spilled discussing the acquisition of Ranbaxy from Daiichi by Sun Pharma in an all stock transaction. A good analysis by a former Ranbaxy executive…
Exuberant over Inhaled Insulin Again?
Yesterday, MannKind Corporation annouced that the FDA voted 13-1 in favor of an approval for Afrezza. You can find the press release here. We've Seen This Movie Before For…
Where Is Biotech’s WhatsApp?
This week, the financial press is going bonkers over the acquisition of WhatsApp by Facebook for $19 billion in cash, stock, and Facebook tchotkes. We're not experts in this space,…
- Go to the previous page
- 1
- …
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- …
- 32
- Go to the next page